Home » Newsletters » BioWorld Science

BioWorld Science

April 1, 1999

View Archived Issues

Aurora and Becton Dickinson announce drug development agreement

Procept receives additional patent allowances for PRO-2000

MGI Pharma to promote Ridaura and Luxiq for Connetics

DSMB completes interim evaluation of Maxamine phase III clinical trials

SciClone receives another approval for Zadaxin

Inflazyme lays plans for phase I testing of IPL-576092

Aquila initiates phase IIb testing of Quilimmune-P

New microbially produced inhibitor of HSP expression in development at Mercian

Temporary platelet inhibition by SM-20302 results in sustained antithrombotic efficacy in dog model

Xenova: year-end 1998 highlights

New microtubule-stabilizing agents developed at Schering

Dopaminergic agents for anxiety, depression and Parkinson's disease disclosed by ADIR

Merck & Co. presents new macrolide immunosuppressants

Protein farnesyltransferase inhibitors emerge from Schering-Plough/Pharmacopeia collaboration

More from ACS meeting: Pfizer presents potent new leukotriene antagonists with oral activity

New antimuscarinic piperidine derivative from Taisho inhibits bladder contractions

Dihydropyridines for reversing MDR presented at Japanese scientific meeting this week

Selective N-type VACC blockers under investigation at Warner-Lambert and Elan

First regulatory approval sought for Reminyl for Alzheimer's disease

Aronex regains worldwide marketing rights to Atragen

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...